Chinese english Japanese Germany Korea

Everolimus Hydrolized Impurity

Everolimus Hydrolized Impurity Structure
CAS No.
769905-89-7
Chemical Name:
Everolimus Hydrolized Impurity
Synonyms
Everolimus Impurity 37;seco Everolimus B (~90%);Everolimus Open-Ring Acid Impurity;2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoac...
CBNumber:
CB14631764
Molecular Formula:
C53H85NO15
Molecular Weight:
976.26
MOL File:
769905-89-7.mol
Modify Date:
2023/4/23 13:52:06
Request For Quotation

Everolimus Hydrolized Impurity Properties

Melting point >110°C (dec.)
Boiling point 1010.0±75.0 °C(Predicted)
Density 1.19±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer, Under inert atmosphere
solubility Chloroform (Slightly), Methanol (Slightly)
form Solid
pka 3.24±0.20(Predicted)
color Light Beige to Brown

Everolimus Hydrolized Impurity Chemical Properties,Uses,Production

Uses

seco Everolimus B is a metabolite of Everolimus (E945400); an immunosuppressant macrolide and analog of the parent drug Rapamycin (R124000). Everolimus inhibits cytokine-mediated lymphocyte proliferation.

Everolimus Hydrolized Impurity Preparation Products And Raw materials

Raw materials

Preparation Products

Everolimus Hydrolized Impurity Suppliers

Global( 17)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6257 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6739 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6754 58 Inquiry
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657 China 10608 58 Inquiry
QUALITY CONTROL SOLUTIONS LTD. 0755-66853366; 13670046396 China 24342 58 Inquiry
Henan Vcommend Consultrading Co., Ltd. 13393721940; 13393721940 China 9985 58 Inquiry
SHANG HAI WEI LING BIOTECHNOLOGY CO.,LTD 13917490980; 13917490980 China 369 58 Inquiry
Cato Research Chemicals Inc. 18933936954 China 17709 58 Inquiry
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696，15000506266 15000506266 China 4613 55 Inquiry
Aikon International Limited 18651614124 China 9199 58 Inquiry
Supplier Advantage
CLEARSYNTH LABS LTD. 58
Pharmaffiliates Analytics and Synthetics P. Ltd 58
Pharma Affiliates 58
Shanghai Zerui Biotechnology Co., Ltd. 58
QUALITY CONTROL SOLUTIONS LTD. 58
Henan Vcommend Consultrading Co., Ltd. 58
SHANG HAI WEI LING BIOTECHNOLOGY CO.,LTD 58
Cato Research Chemicals Inc. 58
Shanghai Lollane Biological Technology Co.,Ltd. 55
Aikon International Limited 58

769905-89-7(Everolimus Hydrolized Impurity)Related Search:

Everolimus 2-Piperidinecarboxylic acid, 1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-dioxo-5-heptenyl es... 42-O-[(1,1-Dimethylethyl)dimethylsilyl]rapamycin Everolimus EP Impurity E USDOYNAPNXMXOE-SPSCNLKESA-N
Everolimus Impurity 1 23,27-Epoxy(7E,15E,17E,19E)-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexam... Everolimus Related Compound 3 EveroliMus-d4 Everolimus Related Compound 2
Rapamycin, 32-O-demethyl- Seco Rapamycin 28-epirapamycin Everolimus Ring-Opening Impurity 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone
chevron_left

1of3

chevron_right
Everolimus Open-Ring Acid Impurity seco Everolimus B (~90%) Everolimus Impurity 37 2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoac... 769905-89-7